Ken Ma, diagnosed with prostate cancer in late 2010 shares his treatment journey along with his disease progression over the last ten years. He shares his decision to follow an aggressive and proactive approach to his treatment regimen, what approaches he saw success in, and what approaches failed him. Further in his disease progression, Mr. Ma was found to have a pathogenic mutation. Mr. Ma shares the importance of finding a team of physicians you trust and have faith in.

Biographies:

Ken Ma, Prostate Cancer Patient

Related Content:

Why Precision Matters: Implications of Genomic Analysis for mCRPC

Riding High on MSI

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

Making Your Treatment Decision - Prostate Cancer Patient Interview with Andy Schwartz

A Prostate Cancer Patient Journey, a Spouse's View - Becky McLain